Loading clinical trials...
Loading clinical trials...
Bridge-Enhanced ACL Repair-Safety Study
This study will assess the safety and early efficacy of a newly developed device, bridge-enhanced scaffold (MIACH™,) used to repair a torn anterior cruciate ligament (ACL.) Ten participants will undergo surgery with the new device (Experimental Group) and 10 will undergo a standard ACL reconstruction surgery (Control Group.)
This is a first-in-human trial for evaluation of the safety (Primary Objective) and short-term efficacy (Secondary Objective) of the MIACH™ ACL scaffold and will be carried out in form of an observational study of 20 patients: 10 experimental and 10 control.
Age
18 - 35 years
Sex
ALL
Healthy Volunteers
No
Boston Children's Hospital
Boston, Massachusetts, United States
Start Date
January 1, 2015
Primary Completion Date
March 19, 2018
Completion Date
December 31, 2026
Last Updated
December 17, 2025
20
ACTUAL participants
ACL Repair with MIACH Scaffold
DEVICE
Standard ACL Reconstruction
PROCEDURE
Lead Sponsor
Miach Orthopaedics
NCT05174611
NCT07475351
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions